Research Article

The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial

Table 1

Baseline characteristics of the subjects in the study.

VariableGroup AGroup BGroup CGroup DF valueP value

Samples (n)35343633
Age (years)56.53 ± 9.1851.59 ± 10.3156.00 ± 9.4754.57 ± 10.541.7330.163
Sex (male/female)23/1225/924/1222/110.892
BMI (kg/m2)25.69 ± 3.2425.40 ± 3.9726.60 ± 3.4225.74 ± 2.730.8300.480
FPG (mmol/L)8.77±1.538.89±2.158.65±1.488.33±1.460.6670.574
2h-PG (mmol/L)13.60±2.8314.35±3.3613.79±2.4813.26±2.868.8340.478
HbA1c (%)7.88 ± 0.787.83 ± 0.697.94 ±0.638.09 ±0.880.7310.535
FINS (mU/L)13.73±7.5814.42±10.3114.65±7.9212.50±6.990.4550.714
2h-INS(mU/L)63.45±47.0169.40±58.9560.48±31.7646.20±33.541.6630.178
SBP(mmHg)136.06±13.32136.38±15.89137.28±18.39131.30±15.560.9580.415
DBP(mmHg)83.06±7.6484.15±8.9984.61±12.4180.42±9.651.2200.305
Triglyceride (mmol/L)1.66 ± 0.802.17 ± 1.391.81 ± 0.912.15 ±2.121.1360.337
Total cholesterol (mmol/L)4.91 ± 1.035.17 ± 0.915.10± 1.005.32±1.030.9660.411
LDL-C (mmol/L)3.18 ± 1.012.97 ± 0.863.19 ± 0.813.30 ±0.970.7420.529
HDL-C (mmol/L)1.13 ± 0.231.15± 0.261.16 ± 0.281.20 ±0.300.3840.765
TCM symptom scale7.14 ± 4.746.88 ±5.387.94 ±6.138.67±5.670.7290.536
TIR (%)67.15±29.2955.47±33.2975.44±25.4281.87±19.895.6610.001
SD1.74±0.691.96±0.951.63±0.571.55±0.562.0790.106
CV (%)18.87±5.8320.28±8.6018.74±5.1518.94±6.270.4100.746

Group A, control group; Group B, Jinlida group; Group C, metformin group and Group D, combination with Jinlida and metformin group. BMI, body mass index; FPG, fasting plasma glucose; 2h-PG, 2-hour postprandial glucose; HbA1c, hemoglobin A1c; FINS, fasting insulin; 2h-INS, 2 hour insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TCM, traditional Chinese medicine; TIR, time in range; SD, standard difference; CV, coefficient of variation.